AAO 2020: Alimera highlights NEW DAY Study for sustained-release intravitreal implant

Video
Conference|AAO

Rick Eiswirth, president and CEO of Alimera Sciences, provides an update on the company’s clinical trial that aims to evaluate its fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien) as a baseline therapy for diabetic macular edema.


Rick Eiswirth, president and CEO of Alimera Sciences, provides an update on the company’s clinical trial that aims to evaluate its fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien) as a baseline therapy for diabetic macular edema.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
Victor Gonzalez, MD, speaks about his Clinical Trials at the Summit presentation, focusing on retinitis pigmentosa therapy MCO-010 (Nanoscope Therapeutics)
Related Content
Q&A: David Eichenbaum, MD, on the ARCHER-2 study for dry AMD and GA

Q&A: David Eichenbaum, MD, on the ARCHER-2 study for dry AMD and GA

David A. Eichenbaum, MD, FASRS;Sydney M Crago;Martin David Harp
August 14th 2025
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
August 14th 2025
Podcast
ASRS 2025: Outcomes in patients with noninfectious uveitis requiring secondary lens implantation

ASRS 2025: Outcomes in patients with noninfectious uveitis requiring secondary lens implantation

Sruthi Arepalli, MD;Martin David Harp;Sydney M Crago
August 14th 2025
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
August 14th 2025
Podcast
Q&A: Jennifer I. Lim, MD, shares insights from the DAVIO-2 study

Q&A: Jennifer I. Lim, MD, shares insights from the DAVIO-2 study

Jennifer Lim, MD, FARVO, FASRS;Sydney M Crago;Martin David Harp
August 14th 2025
Article
Q&A: Matthew Starr, MD, shares his experience using scleral suture toric intraocular lenses for patients with significant corneal astigmatism

Q&A: Matthew Starr, MD, shares his experience using scleral suture toric intraocular lenses for patients with significant corneal astigmatism

Matt Starr, MD;Sydney M Crago;Martin David Harp
August 14th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.